Ozempic is an FDA-approved prescription medication for people with type 2 diabetes while Wegovy is FDA-approved for chronic obesity. They’re brand names for semaglutide, a GLP-1 receptor agonist ...
Opens in a new tab or window Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), were originally approved for type 2 diabetes ...